Infliximab Paediatric Crohn’s Disease Educational Plan

[1]  R. Wallis.  Infectious complications of tumor necrosis factor blockade , 2009, Current opinion in infectious diseases.

[2]  黄亚明.  MedScape , 2009 .

[3]  W. Sandborn,et al.  Inflammatory bowel disease: clinical aspects and established and evolving therapies , 2007, The Lancet.

[4]  Mark Avigan,et al.  Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. , 2007, Journal of pediatric gastroenterology and nutrition.

[5]  A. Silman,et al.  Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. , 2006, Arthritis and rheumatism.

[6]  A. Lapidus.  Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. , 2006, World journal of gastroenterology.

[7]  M. Lebwohl,et al.  The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. , 2005, Seminars in arthritis and rheumatism.

[8]  P. Lakatos,et al.  Selection criteria for preoperative endoscopic retrograde cholangiopancreatography before laparoscopic cholecystectomy and endoscopic treatment of bile duct stones: results of a retrospective, single center study between 1996-2002. , 2004, World journal of gastroenterology.

[9]  P. Lakatos,et al.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. , 2004, World journal of gastroenterology.

[10]  R. Hoffmann,et al.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. , 2003, The Journal of pediatrics.

[11]  M. Frommer,et al.  Criteria for evaluating evidence on public health interventions , 2002, Journal of epidemiology and community health.

[12]  P. Schoenfeld,et al.  The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review , 2002, Alimentary pharmacology & therapeutics.

[13]  P. J. Kelly,et al.  Inflammatory bowel disease: epidemiology and management in an English general practice population , 2000, Alimentary pharmacology & therapeutics.

[14]  D. Jewell,et al.  A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.

[15]  Bobby Milstein,et al.  Framework for program evaluation in public health , 1999 .

[16]  J. J. Andonian.  Maxcy-Rosenau-Last Public Health and Preventive Medicine , 1999 .

[17]  Joseph A. Durlak,et al.  Why Program Implementation is Important , 1998 .

[18]  A. Zinsmeister,et al.  Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. , 1998, Gastroenterology.

[19]  R. Pounder,et al.  Prevalence of inflammatory bowel disease in British 26 year olds: national longitudinal birth cohort , 1998, BMJ.

[20]  I. Scott.  You can't believe all that you're told: the issue of unvalidated questionnaires. , 1997, Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention.

[21]  D. Palli,et al.  A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). , 1996, Scandinavian journal of gastroenterology.

[22]  D A Asch,et al.  Timing payments to subjects of mail surveys: cost-effectiveness and bias. , 1995, Journal of clinical epidemiology.

[23]  J. Thompson,et al.  Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. , 1993, Gut.

[24]  M. Glados,et al.  [Data on the epidemiology of Crohn disease in the city of Cologne]. , 1993, Medizinische Klinik.

[25]  J. Kyle,et al.  Crohn's disease in the northeastern and northern Isles of Scotland: an epidemiological review. , 1992, Gastroenterology.

[26]  S. Kreiner,et al.  Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. , 1992, Scandinavian journal of gastroenterology.

[27]  E. Lindberg,et al.  The incidence of Crohn's disease is not decreasing in Sweden. , 1991, Scandinavian journal of gastroenterology.

[28]  V. Jureša,et al.  Epidemiology of Crohn's disease in Zagreb, Yugoslavia: a ten-year prospective study. , 1991, International journal of epidemiology.

[29]  F. Brahme,et al.  Crohn's disease in a defined population. An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmö, Sweden. , 1975, Gastroenterology.

[30]  A. Zinsmeister,et al.  Erratum: Crohn's disease in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival (Gastroenterology (1998) 114 (1161- 1168)) , 1999 .

[31]  S. Wallerstedt,et al.  Prevalence of Crohn's disease and simultaneous occurrence of extraintestinal complications and cancer. An epidemiologic study in adults. , 1996, Scandinavian journal of gastroenterology.

[32]  D. Vicent,et al.  Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988. , 1994, Journal of clinical gastroenterology.

[33]  M. Scheurlen,et al.  Epidemiology of inflammatory bowel disease in the county of Tübingen (West Germany). , 1989, Scandinavian journal of gastroenterology. Supplement.